AU472734B2 - Dopamine derivatives - Google Patents

Dopamine derivatives

Info

Publication number
AU472734B2
AU472734B2 AU54385/73A AU5438573A AU472734B2 AU 472734 B2 AU472734 B2 AU 472734B2 AU 54385/73 A AU54385/73 A AU 54385/73A AU 5438573 A AU5438573 A AU 5438573A AU 472734 B2 AU472734 B2 AU 472734B2
Authority
AU
Australia
Prior art keywords
methyl
phenethylamine
acid
dihydroxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU54385/73A
Other languages
English (en)
Other versions
AU5438573A (en
Inventor
RALPH TUTTLE and JACK MILLS RONALD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU472734(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU5438573A publication Critical patent/AU5438573A/en
Application granted granted Critical
Publication of AU472734B2 publication Critical patent/AU472734B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54385/73A 1972-04-12 1973-04-11 Dopamine derivatives Expired AU472734B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12
USUS243,466 1972-04-12

Publications (2)

Publication Number Publication Date
AU5438573A AU5438573A (en) 1974-10-17
AU472734B2 true AU472734B2 (en) 1976-06-03

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54385/73A Expired AU472734B2 (en) 1972-04-12 1973-04-11 Dopamine derivatives

Country Status (31)

Country Link
JP (2) JPS5825656B2 (enExample)
KR (1) KR790000113B1 (enExample)
AR (1) AR203822A1 (enExample)
AT (1) AT323719B (enExample)
AU (1) AU472734B2 (enExample)
BE (1) BE798051A (enExample)
BG (1) BG23001A3 (enExample)
CA (1) CA1018188A (enExample)
CH (2) CH569691A5 (enExample)
CS (2) CS190406B2 (enExample)
CY (1) CY963A (enExample)
DD (1) DD107670B3 (enExample)
DE (1) DE2317710C2 (enExample)
DK (1) DK142750C (enExample)
ES (1) ES413639A1 (enExample)
FR (1) FR2182947B1 (enExample)
GB (1) GB1392674A (enExample)
HK (1) HK50178A (enExample)
HU (2) HU166213B (enExample)
IE (1) IE37511B1 (enExample)
IL (1) IL42016A (enExample)
KE (1) KE2870A (enExample)
MY (1) MY7800381A (enExample)
NL (1) NL174459C (enExample)
PH (1) PH11041A (enExample)
PL (2) PL90695B1 (enExample)
RO (2) RO70892A (enExample)
SE (1) SE399064B (enExample)
SU (1) SU496719A3 (enExample)
YU (2) YU36483B (enExample)
ZA (1) ZA732136B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (enExample) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (enExample) * 1989-12-18 1991-08-23
WO1992020645A1 (en) * 1991-05-20 1992-11-26 Tsumura & Co. Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
US7642290B2 (en) 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
RU2012107457A (ru) 2009-07-31 2013-09-10 Когнишн Терапьютикс, Инк. Ингибиторы ухудшения когнитивных способностей
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
WO2013029057A2 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
WO2015116923A1 (en) 2014-01-31 2015-08-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
ES3063712T3 (en) 2017-05-15 2026-04-20 Cognition Therapeutics Inc Compositions for treating neurodegenerative diseases
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
ES413639A1 (es) 1976-01-16
NL174459B (nl) 1984-01-16
IL42016A (en) 1976-05-31
YU37113B (en) 1984-08-31
ZA732136B (en) 1974-03-27
HU167597B (enExample) 1975-11-28
YU97673A (en) 1982-02-25
KR790000113B1 (en) 1979-03-20
KE2870A (en) 1978-09-01
RO65105A (ro) 1980-01-15
NL7305097A (enExample) 1973-10-16
SE399064B (sv) 1978-01-30
SU496719A3 (ru) 1975-12-25
PL90695B1 (enExample) 1977-01-31
FR2182947B1 (enExample) 1976-07-02
JPS6221343B2 (enExample) 1987-05-12
RO70892A (ro) 1982-02-26
AU5438573A (en) 1974-10-17
IE37511B1 (en) 1977-08-03
NL174459C (nl) 1984-06-18
PL94207B1 (enExample) 1977-07-30
BE798051A (fr) 1973-10-11
DK142750C (da) 1981-08-17
CS190406B2 (en) 1979-05-31
CY963A (en) 1978-12-22
DD107670B3 (de) 1988-04-06
PH11041A (en) 1977-10-25
YU36483B (en) 1984-02-29
BG23001A3 (bg) 1977-05-20
MY7800381A (en) 1978-12-31
CH569691A5 (enExample) 1975-11-28
HK50178A (en) 1978-09-15
CS190448B2 (en) 1979-05-31
JPS58131945A (ja) 1983-08-06
JPS497237A (enExample) 1974-01-22
YU321279A (en) 1983-04-27
CA1018188A (en) 1977-09-27
HU166213B (enExample) 1975-02-28
DE2317710C2 (de) 1983-08-04
IL42016A0 (en) 1973-06-29
AT323719B (de) 1975-07-25
AR203822A1 (es) 1975-10-31
GB1392674A (en) 1975-04-30
DD107670A5 (de) 1974-08-12
DE2317710A1 (de) 1973-10-18
CH580563A5 (enExample) 1976-10-15
DK142750B (da) 1981-01-12
FR2182947A1 (enExample) 1973-12-14
JPS5825656B2 (ja) 1983-05-28

Similar Documents

Publication Publication Date Title
CA1018188A (en) Dopamine derivatives
AU467361B2 (en) Q-aryl-4-substituted piperidinoalkanol derivatives
AU496759B2 (en) New pregnan-21-oic derivatives
AU470719B2 (en) Oxazinoindole-and thiazinoinindole derivatives
CA1019738A (en) Isothiocyanopyridine derivatives
AU467405B2 (en) Diphenylalkyllactamimide derivatives
CA1020946A (en) 1-phenoxy-3-phenoxyethylamino-2-propanol derivatives
AU470763B2 (en) Pyrano-and thiopyranoindole derivatives
CA1018161A (en) Indan-1-carboxamide derivatives
CA1006514A (en) Beta-aminoketone derivatives
CA978526A (en) Pyrano- and thiopyranoindole derivatives
AU477427B2 (en) 2-fluoro-substituted thiazanthene derivatives
AU483221B2 (en) Benzo-di-pyran derivatives
AU482792B2 (en) Indan-1-carboxamide derivatives
AU485463B2 (en) New isothiocyanopyridine derivatives
AU485918B2 (en) New phenylformamidine derivatives
AU484135B2 (en) New beta-aminoketone derivatives
CA981684A (en) Cyclopenteno-quinolone derivatives
CA910910A (en) Pyrimidinylpyrazole derivatives
CA917653A (en) N-sulphonamide-succinimide derivatives
CA904885A (en) 1-amino-3-phenoxy-2-propanol derivatives
CA892056A (en) Sulphonamidopyrazolinone derivatives
CA916153A (en) Dihydropyrimidopyridazine derivatives
CA899886A (en) Oxotremarine derivatives
CA898253A (en) Styryl-naphthalene derivatives